Wealth Enhancement Advisory Services, LLC Argenx Se Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Argenx Se stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 370 shares of ARGX stock, worth $329,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
370Holding current value
$329,166% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
499Shares Held
28MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$4.43 Billion0.31% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$2.28 Billion0.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.95 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.74 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$1.05 Billion11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $49.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...